Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Rerep-Seq of cadmium resistant breast cancer MDA-231 cells

ABSTRACT: Rerep-Seq of cadmium resistant breast cancer MDA-231 cells

PROVIDER: PRJNA698369 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

H3K27me3 CHIP-seq of cadmium resistant breast cancer MDA-231 cells

Project description:In this study we compared genome wide H3K27me3 CHIP-seq of cadmium resistant MDA-231 breast cancer cells vs untreated controls

2021-07-13 | GSE179822 | GEO

ATAC-seq in cadmium resistant breast cancer MDA-MB-231 cells

Project description:In this study, we compared ATAC-seq of cadmium resistant MDA-MB-231 cells vs untreated controls.

2023-02-20 | GSE216496 | GEO

RNA-seq in cadmium resistant breast cancer MDA-MB-231 cells

Project description:In this study, we compared RNA-seq of cadmium resistant MDA-MB-231 cells vs untreated controls.

2023-02-20 | GSE220803 | GEO

CUT&RUN in cadmium resistant breast cancer MDA-MB-231 cells

Project description:In this study, we compared MTF-1 CUT&RUN of cadmium resistant MDA-MB-231 cells vs untreated controls.

2023-02-20 | GSE222587 | GEO

Cut and Run ChIP-seq of SUZ12 and EZH2 in cadmium resistant breast cancer MDA-231 cells

Project description:In this study we compared genome wide SUZ12 and EZH2 Cut&RUN CHIP-seq of cadmium resistant MDA-231 breast cancer cells vs untreated controls.

2021-07-13 | GSE179823 | GEO

H3K27me3 CHIP-seq of cadmium resistant breast cancer MDA-231 cells

Project description:H3K27me3 CHIP-seq of cadmium resistant breast cancer MDA-231 cells

| PRJNA745180 | ENA

H3K27me3 chip-seq in cadmium resistant 231 breast cancer cells

Project description:In this study we investigate genome wide changes in H3K27me3 with respect to cadmium resistance in MDA-MB-231 cells.

2021-02-01 | GSE165864 | GEO

H3K27me3 chip-seq in cadmium resistant 231 breast cancer cells

Project description:H3K27me3 chip-seq in cadmium resistant 231 breast cancer cells

| PRJNA698367 | ENA

Gene expression data of sensitive, Docetaxel resistant and Paclitaxel resistant MDA-MB-231 Cells

Project description:The taxanes, namely Paclitaxel and Docetaxel, are important and widely used cancer chemotherapy drugs in the treatment of invasive and metastatic human breast cancer. Although treatment with the taxanes is beneficial to many patients, drug-responsive tumors in patients with metastatic breast cancer often display resistance to these drugs, either initially or over time following the continued administration of chemotherapy drugs. To investigate the patterns of cross-resistance with the taxane drugs and to identify potential mechanisms of resistance, we generated a series of MDA-MB-231 taxane resistant cell lines. We then used microarrays to determine gene expression differences between sensitive, Docetaxel and Paclitaxel resistant MDA-MB-231 cells.

2011-04-22 | GSE28784 | GEO